Gastrointestinal Infection
14
2
3
5
Key Insights
Highlights
Success Rate
83% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
7.1%
1 terminated out of 14 trials
83.3%
-3.2% vs benchmark
21%
3 trials in Phase 3/4
20%
1 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (14)
Wells and Enteric Disease Transmission
VItamin D in pregnanCy for prevenTion Of eaRlY Childhood Asthma
Fish Oil in pREgnancY for Personalized Prevention of Early Childhood Asthma
Wells and Enteric Disease Transmission Trial (WET - Trial)
Comparing Oral Versus Parenteral Antimicrobial Therapy
Clinical Performance of QIAstat-Dx® Gastrointestinal Panel 2
Preventive Effect of Cow's Milk Fermented With Lactobacillus Paracasei CBA L74 on Common Infectious Diseases in Children
Therapeutic Endoscopic Ultrasound for Gastrointestinal Disorders: A Multicenter Registry Study
The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia Areata
Efficacy of AEMCOLO (Rifamycin SV MMX) in the Treatment of Small Intestinal Bacterial Overgrowth (SIBO)
Telemedicine and Face-to-face Consultations Diagnostic Accuracy Comparison in Gastrointestinal Infection Patients
Kent State University / Price Chopper Employee Wellness Study
Specimen Collection and Transport Workflow Evaluations for CLIA-waived Molecular Testing
Identification of Host Factors of Norovirus Infections in Mini-Gut Model